SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

SVB Leerink Maintains Outperform on Biohaven Pharma Hldgs, Lowers Price Target to $105

SVB Leerink analyst Marc Goodman maintains Biohaven Pharma Hldgs (NYSE:BHVN) with a Outperform and lowers the price target from $115 to $105.

05/12/2021 06:17
SVB Leerink analyst Marc Goodman maintains Biohaven Pharma Hldgs (NYSE:BHVN) with a Outperform and lowers the price target from $115 to $105.